Current Status and Future Promise of Pharmacotherapeutic Strategies for Alzheimer's Disease

The paradigm that AD is pharmacologically unresponsive is shifting. Our understanding of the molecular mechanisms of neurodegeneration will soon allow us to more specifically target and interrupt the processes that contribute to this dementia.